Program 2019-09-25T20:23:17+00:00

Program

Click here to view our interactive eProgram.

ACCREDITATION

This conference has been organized in collaboration with the University of Calgary.

This event is an Accredited Group Learning Activity (Section 1) as defined by the Maintenance of Certification Program of the Royal College of Physicians and Surgeons of Canada, and approved by the University of Calgary Office of Continuing Medical Education and Professional Development. You may claim a maximum of 16.5 hours (credits are automatically calculated).

Claiming your credits: Visit MAINPORT https://mainport.royalcollege.ca to record your learning and outcomes.

This Group Learning activity has been certified by the College of Family Physicians of Canada and the Alberta Chapter for up to 16 Mainpro+ credits.

C:\Users\Tom Sam Alex\Google Drive\Public\Graphics\Corporate Logos\CCCEP Accredited.jpg

The Canadian Council on Continuing Education in Pharmacy has accredited this program for 49.54 CEUs.

Each participant should claim only those hours of credit that he/she actually spent participating in the educational program.

Wednesday, September 25, 2019

18:00 – 18:30 Opening Session

Room: British Columbia/Alberta/Yukon

18:30 – 19:30 Keynote Lecture

When Celebrity Culture and Science Clash (60 min)
Dr. Timothy Caulfield

Room: British Columbia/Alberta/Yukon

19:30 – 21:30 President’s Reception

Room: Saskatchewan/Manitoba

19:30 – 21:30 Poster Session # 1
Biomedical Research Track
(This session is not certified)
Room: Saskatchewan/Manitoba
BM1- Association of Endothelial MPs With Glucose Control in Pregnant Women with T1DAkram AbolbaghaeiBM2 – Aldosterone Contributes to Hypertension in Mice Inducibly Overexpressing Human Endothelin-1 in EndotheliumOlga BerilloBM3 – High Salt Feeding Increases Uromodulin Excretion Associated With Hypertension and Decline in Renal FunctionRachel CarlisleBM4 – Transactivation of the Insulin Receptor through G-Protein-Coupled Receptor Biased Agonism: A Novel Therapeutic Target for Metabolic SyndromeRegina Veronicka Kalaydina

BM5 – Potential Effect of Diet on Vitamin B12 Availability and Biochemistry of Hypertensive Animal Models

Kayla Kitselman

BM6 – The Role of Peptidylarginine Deiminase 4 and Neutrophil Extracellular Traps in Vascular and Renal Function in Hypertensive Diabetic Mice

Chloé Landry

19:30 – 21:30 Poster Session # 1
Clinical Research Track
(This session is not certified)
Room: Saskatchewan/Manitoba
C1 – The Impact of Occupational Activity on Risk of Developing Hypertensive Disorders of PregnancyRshmi KhuranaC2 – Detection of Audible Korotkoff Sounds Based on Human Hearing ThresholdsMariana Alvarado AlvarezC3 – Prevalence and Awareness of Hypertension in Young Women with Chronic Kidney Disease Danica ChangC4 – Transition in Care for Hypertension : Experience of Teenagers and Their Families

Simon Chauvette

C5 – Ambulatory Blood Pressure Monitoring Abnormalities in Relation to Post-Operative AKI 9-Years After Pediatric Cardiac Surgery

Daniel Fredric

C6 – Antihypertensive Drug Shortages: Implications for Patients and Primary Care Providers

Rebecca Sedore

C8 – Pharmacists Improving Hypertension Care – But You Have To Pay Them… A review of remuneration opportunities across Canada

Jonathan Chan

Thursday, September 26, 2019

7:45 – 8:45 Hypertension Canada’s Annual General Meeting & Award Presentations with Continental Breakfast

Room: Saskatchewan/Manitoba

09:00 – 10:30 Hypertension Canada Award Lectures

Jacques de Champlain New Investigator Award Lecture

Protein Folding in Hypertension, Regulator of the Blood Vessel (30 min)

Dr. Jeffrey Dickhout

Senior Investigator Award Lecture ‎

Blood Pressure: The Neglected Biomarker (30 min)

Dr. John Floras

George Fodor Award Lecture

Bridging the Gap: From Science to Action: Strategies for Dissemination and Implementation of Hypertension Canada’s Guidelines (30 min)

Dr. Denis Drouin

Room: British Columbia/Alberta/Yukon

10:30 – 11:00 Networking & Health Break in Foyer
11:00 – 12:30 Update on the Activities of Chair in Hypertension Prevention & Control (30 min)

Dr. Janusz Kaczorowski

CIHR Chair Symposium

Optimising the Development of Behavioural Interventions: Qualitative & Quantitative Methods & the Incorporation of Patients & Stakeholders (60 min)

Dr. Claudi Gemme

Room: British Columbia/Alberta/Yukon

Antihyperglycemic Agents & Reducing CV Risk: Practical Application of Diabetes Canada’s Clinical Practice Guidelines (45 min)

Dr. Peter Senior

From Rest to Stressed: Adults with Type 2 Diabetes Exhibit a Greater Exercise-Induced Increase in Arterial Stiffness and Vessel Hemodynamics (15 min)

Alexandra Cooke

Efficacy and Safety of Fixed Dose Combination of Candesartan and Rosuvastatin on Blood Pressure and Cholesterol in Patients with Hypertension and Hypercholesterolemia (15min)

Chang Gyu Park

Increased Acute Vascular Deposition of Radioactive Phosphate is an Index of Calcification Activity (15 min)

Mandy Turner

Room: Manitoba

Gestational Hypertension/ISSHP Canada

Postpartum Hypertension Management (30 min)

Dr. Laura Magee

Pregnancy and Future Cardiovascular Health: An Opportunity for Prevention (30 min)

Dr. Kara Nerenberg

Firing Patterns of Sympathetic Vasomotor Neurons in Response to Antihypertensive Drugs in Complicated Pregnancies (15 min)

Molly Henneberry

Perinatal Iron Deficiency Causes Systolic Dysfunction and Structural Changes in the Hearts of Neonatal Offspring (15 min)

Ronan Noble

Room: Turner Valley

12:30 – 13:30 Lunch

Room: Saskatchewan/Manitoba

13:30 – 14:30 Women in Hypertension

Panel Discussion (60 min)

Dr. Nadia Khan (Moderator), Dr. Doreen Rabi (Clinical Endocrinologist), Dr. Ulrike Muscha Steckelings (Pharmacology), Dr. Kim Kelly (Family Physician), Dr. Robert Gros (Scientist)

(This session is not certified)

Room: British Columbia/Alberta/Yukon

14:30 – 16:00 Effects of SGLT2 Inhibitors on Blood Pressure & Other Cardiovascular Risk Factors (30 min)

Dr. Lorraine Lipscombe

Investigating Putative Targets for the Direct Cardiac Effects of SGLT2 Inhibitors at the Whole Heart, Cellular & Molecular Levels (60 min)

Drs. Peter Light & David Cherney

Room: British Columbia/Alberta/Yukon

Measurement of Blood Pressure in People With Atrial Fibrillation: A Statement on Behalf of the British and Irish Hypertension Society (15 min)

Christopher Clarke

Sex, Age and Muscle Sympathetic Nerve Activity in Healthy Normotensive Volunteers (15 min)

Daniel Keir

Natriuretic Peptide Receptors as Novel Targets for Atrial Fibrillation in Ang II Induced Hypertension (30 min)

Dr. Robert Rose

Central Control of Salt Sensitivity and Blood Pressure (30 min)

Dr. Richard Wainford

Room: Manitoba

Gestational Hypertension/ISSHP Canada

New 2019 Canadian Guideline for Physical Activity throughout Pregnancy (30 min)

Dr. Michelle Mottola

Metabolic Alterations Associated with Preeclampsia (30 min)

Dr. Julie Lavoie

The Impact of Aerobic Exercise Intervention on Sympathetic Reflex Activation During Cold Pressor Test During Normotensive Pregnancy (15 min)

Rachel Skow

Home Blood Pressure Monitoring in the Diagnosis and Treatment of Hypertension in Pregnancy: A Systematic Review and Meta-Analysis (15 min)

Karen Tran

Room: Turner Valley

16:00 – 16:30 Networking & Health Break in Foyer
16:30 – 18:00 miR-338-3p Down-Regulation Caused Up-Regulation of Alkaline Ceramidase 2 and Glutathione Peroxidase 3 mRNAs in Subcutaneous Small Arteries of Hypertensive Patients with Chronic Kidney Disease

(15 min)

Pierre Paradis

A Novel Murine Model for the Study of Lung Microvascular Regeneration Following Diphtheria Toxin Mediated Endothelial Cell Ablation (15 min)

Rafael Soares Godoy

Stroke Best Practices Recommendations (30 min)

Dr. Michael D. Hill

Hypertension in Lacunar Small Vessel Disease & its Relationship to Inflammation (30 min)

Dr. Glen Jickling

Room: British Columbia/Alberta/Yukon

Hypertension in Patients with CKD (30 min)

Dr. Branko Braam

Evaluating the Efficacy of Primary Aldosteronism Therapy (30 min)

Dr. Gregory Hundemer

A Connexin40 (Cx40) Knockout Rat is a Model for the Study of Renal and Other Mesocirculations (15 min)

William Cupples

Contrasting Mechanisms in two Experimental Models of Vascular Calcification: Adenine-Induced Chronic Kidney Disease Versus Non-CKD High Dose Calcitriol Treatment (15 min)

Austin Lansing

Room: Manitoba

Perinatal Nephron Programming is not so Sweet in Maternal Diabetes (30 min)

Dr. Shao-Ling Zhang

Circulating Microparticles and Maternal Fetal Complications in Pregnant Women with T1D

(15 min)

Akram Abolbaghaei

Sex-Specific Changes in Neonatal Cardiac Mitochondrial Function in Response to Perinatal Iron Deficiency

(15 min)

Claudia Holody

Tumor Necrosis Factor Alpha (TNF-α) Polymorphisms are Associated with High Risk of Preeclampsia (15 min)

Nozha Raguema

Muscle Sympathetic Nervous System Activity in Women With Gestational Diabetes (15 min)

Laura M. Reyes

Room: Turner Valley

18:00 – 19:00 Mix & Mingle Reception

Room: North Foyer

18:00 – 19:00 Poster Session # 2

Biomedical Research Track

(This session is not certified)

Room: North Foyer

BM1 – Alterations in Parathyroid Gland Responsiveness to Changes in Calcium and Phosphate in Experimental Chronic Kidney Disease

Lok Hang Lee

BM2 – Activation of Endoplasmic Reticulum Stress and Thrombospondin-1 Anti-Angiogenic Mechanisms in Placentas of Hypertensive Pregnancy

Casandra Marc

BM3 – Augmented Myogenic Constriction in the SHR Pre-Glomerular Vessels is Mediated by Renal Prostanoid Synthesis

Samera Nademi

BM4 – Role of Stress Inducible Protein (STI-1) During Cardiac Development and Pathological Hypertrophy

Iara Nogueira

BM5 – Introgression of Brown Norway Chromosome 2 Fragment into Hypertensive Dahl Salt-Sensitive Background Stimulates Inflammation Under High-Salt Diet

Olga Berillo

BM6 – Inhibition of Sirtuin-1 Overexpression Attenuates Hypertension and Tachycardia in Spontaneously Hypertensive Rats: Role of Giα Protein and Nitro-Oxidative Stress

Mst Nahida Arifen

18:00 – 19:00 Poster Session # 2 Clinical Research Track

(This session is not certified)

Room: North Foyer

C1 – Real World Implementation of Diabetes Management by Pharmacists: The RxING Practice Tool

Yazid N Al Hamarneh

C2 – Arteriovenous Fistula, Blood Pressure and Arterial Reservoir-Wave Analysis: Lessons From End-Stage Renal Disease

Mathilde Paré

C3 – The Impact of Hospitalization on Physical Activity During Pregnancy

Florence Liu

C4 – Considering the Community as a Key Stakeholder in Hypertension Knowledge Translation: Experiences from Western Province, Zambia

Danielle McDivitt

C5 – The Ability of Automated Office BP Measurement to Accurately Predict the Presence of Hypertension, Based on 24-hour ABPM, After a Single Elevated Office BP Measurement

André Michaud

C6 – Interactive Effects of Physical Fitness and Body Mass Index on Risk of Hypertension

Samia Rizk

C7 – Prevalence of Essential Hypertension in Postural Orthostatic Tachycardia Syndrome (POTS)

Eliz Hasbay

C8 – A Longitudinal Analysis of Arterial Stiffness and Wave Reflection in Preeclampsia: Identification of Changepoints

Kim Phan

19:00 Dinner on Own
19:30 Young Investigator Forum Programming Social Event

Friday, September 27, 2019

07:45 – 08:45 Breakfast

Room: Saskatchewan/Manitoba

09:00 – 10:30 The Real Challenges Primary Care Faces in the Management of Hypertension (90 min)
Dr. Richard Lewanczuk (Moderator), Dr. Peter Hum (Family Physician), Ms. Lonni Johnson (Pharmacist) & Ms. Ada Vanderheide (Patient)Room: British Columbia/Alberta/Yukon
10:30 – 11:00 Networking & Health Break in Foyer
11:00 – 12:00 Addressing Current NCD Epidemics Through Improved Community Environments

(20 min)

Dr. Karen Lee

Beyond Traditional Screening: How to ‘Case Find’ Those Who Need Our Help (20 min)

Dr. Yazid Al Hamarneh

Geographical Clustering of Hypertension Rate in the Canadian Population: A Geostatistical Analysis (15 min)

Lyne Cloutier

Room: British Columbia/Alberta/Yukon

Celiac Disease and Oral Felodipine Pharmacokinetics – Consequences for Prescribing Cardiovascular Medications

(15 min)

Marc Chretien

Nitric Oxide-activating Angiotensin II Receptor Blockers in Marfan Syndrome: Time to Look Beyond Blood Pressure Control (15 min)

Arash Tehrani

Control of Hypertension in Autoimmune Conditions (30 min)

Dr. Fakhreddin Jamali

Room: Manitoba

Pressure from the Bugs Within: Microbiomic & Metabolomic Contributions to Hypertension (30 min)

Dr. Bina Joe

Changes in Hemodynamics and Vascular Function in the Progression of Sepsis to Septic Shock (15 min)

Forough Jahandideh

γδ T Cells Mediate αβ T Cell Activation In Angiotensin II-Induced Hypertension (15 min)

Antoine Caillon

Room: Turner Valley

12:00 – 12:30 Non Certified Session

This session is not certified by the College of Family Physicians of Canada (CFPC) or the Canadian Council on Continuing Education in Pharmacy (CCCEP)

Room: British Columbia/Alberta/Yukon

12:30 – 13:30 Lunch

Room: Saskatchewan/Manitoba

13:30 – 15:00 Hypertension & the Older Patient (20 min)

Dr. Dave Hogan

Practical Tips for Cardiovascular Prevention in the Elderly (20 min)

Dr. Michelle Graham

The Impact of Systolic Inter-Arm Blood Pressure Difference on Cardiovascular Risk Estimation in Primary Care (15 min)

Christopher Clark

Maladaptive Right Ventricular Remodeling in Pulmonary Arterial Hypertension is Associated With Decreased Mitochondrial Oxidative Capacity and Impaired Fatty Acid Oxidation (15 min)

Virgilio Cadete

Blood Pressure Regulation in High-altitude Andeans with and without Chronic Mountain Sickness (15 min)

Andrew Steele

Room: British Columbia/Alberta/Yukon

Role Of Vγ6+ γδ T Cells In Angiotensin II-Induced Hypertension And Vascular Injury (15 min)

Ahmad Mahmoud

Impaired Right Ventricular Energetics in Maladaptive Remodeling in Response to Severe Pulmonary Arterial Hypertension (15 min)

Jason Zelt

BP Thresholds & Targets: Challenges & Controversies

(20 min)

Dr. Raj Padwal

Role of 24-hour Ambulatory Blood Pressure Monitoring in Diagnosis & Management of Hypertension (20 min)

Dr. Marcel Ruzicka

Home Blood Pressure Measurement: Advantages & Opportunities for Optimization (20 min)

Dr. Jennifer Ringrose

Room: Manitoba

New Dietary Guidance for Canada: The 2019 Canada’s Food Guide (20 min)

Dr. JoAnne Arcand

Evidence for Diets: Popular Dietary Programs for Weight & Cardiovascular Risk Reduction (20 min)

Dr. Bradley Johnston

Randomized Controlled Trial of Pragmatic and Structured Dietary Counselling by Registered Dietician Compared to Standard of Care Dietary Counselling by a Nurse in a Regional Hypertension Centre: Effect on 24-hour Urinary Sodium (15 min)

Ankur Gupta

Assessment of Apoptosis, Autophagy, and Cellular Senescence in Developing Kidneys Exposed to Perinatal Iron Deficiency (15 min)

Richard Mah

Perinatal Iron Deficiency Combined with a High Salt Diet in Adulthood Causes Sex-Dependent Vascular Dysfunction and Oxidative Stress (15 min)

Andrew Woodman

Room: Turner Valley

15:00 – 15:30 Networking & Health Break in Foyer
15:30 – 16:30 Hypertension and Sleep Apnea: A Bi-Directional Relationship

(30 min)

Dr. John Floras

Long Working Hours and the Prevalence of Masked and Sustained Hypertension (15 min)

Xavier Trudel

Motion Compensated Continuous Blood Pressure Measurements Using Recurrent Neural Networks (15 min)

Shrimanti Ghosh

Room: British Columbia/Alberta/Yukon

Atrial Fibrillation Guideline Rapid Review (30 min)

Dr. Alan Bell

2018 CCS/CAIC Focused Update of the Guidelines for the Use of Antiplatelet Therapy: Antithrombotic Management of Patients with Atrial Fibrillation and Coronary Artery Disease

(15 min)

Dr. Alan Bell

2018 CCS/CAIC Focused Update of the Guidelines for the Use of Antiplatelet Therapy: Duration of Dual Antiplatelet Therapy (15 min)

Dr. Margaret Ackman

Room: Manitoba

Dietary Sodium: Facts and a Call to Action (30 min)

Dr. Norm Campbell

Examining the Impact of Endothelial Bone Morphogenetic Protein Receptor 2 Loss on Interleukin-15 Signaling and the Pathogenesis of Pulmonary Arterial Hypertension (15 min)

L. Rhiannon Hilton

Pyruvate Dehydrogenase Kinase Initiates Warburg Mitochondrial Metabolism in Right Ventricular Fibroblasts and Promotes Right Ventricular Fibrosis in Pulmonary Arterial Hypertension (15 min)

Lian Tian

Room: Turner Valley

16:30 – 17:30 Mix & Mingle Reception

Room: North Foyer

16:30 – 17:30 Poster Session # 3

Biomedical Research Track

(This session is not certified)

Room: North Foyer

BM1 – Human Endothelin-1 Overexpression in Mice Changed Gene Expression in Mesenteric Arteries

Pierre Paradis

BM2 – Evaluation of the Involvement of Placental Apoptosis in the Development of Preeclampsia

Nozha Raguema

BM3 – P2X7 Receptor Plays a Role in Angiotensin II-Induced Hypertension and Vascular Remodeling

Brandon Shokoples

BM4 – Endothelial Colony Forming Cells: A Platform of In Vitro Angiogenesis Microvascular Assessment and Therapeutics Development

Cheryl Tan

16:30 – 17:30 Poster Session # 3

Clinical Research Track

(This session is not certified)

Room: North Foyer

C1 – Unilateral Disease in Patients with Primary Aldosteronism without Apparent Adrenal Nodules

Alexander Leung

C2 – Patient Perceptions of Ambulatory Blood Pressure Monitoring Testing, Tolerability, Accessibility, and Expense

Jennifer Ringrose

C3 – Diabetes Mellitus as a Compelling Indication for Use of Renin Angiotensin System Blockers: Systematic Review of Randomized Trials

Samia Rizk

C4 – Frequency of Laboratory Testing and Associated Abnormalities in Patients with Hypertension

Samuel Quan

C5 – A Scoping Review For Knowledge, Perception and Practice of Health Professionals Regarding Blood Pressure Measurement Methods

Shweta Todkar

C6 – Evaluation of a Microlearning Module on Hypertension for Canadian Healthcare Professionals

Khrystine Waked

17:30 Dinner on Own
19:00 Young Investigator Forum Programming Social Event

Saturday, September 28, 2019

07:45 – 08:45 Breakfast

Room: Saskatchewan/Manitoba

09:00 – 10:00 2020 Hypertension Canada Guidelines Overview (60 min)

Dr. Doreen Rabi and Dr. Stella Daskalopoulou

Room: British Columbia/Alberta/Yukon

10:00 – 10:30 Networking & Health Break in Foyer
10:30 – 11:30

Improving Hypertension Care & Outcomes. How can Implementation Science Help? (60 min)

Drs. Jeremy Grimshaw, Noah Ivers & Justin Presseau

Room: British Columbia/Alberta/Yukon

Treatment of Hypertension in End Stage Renal Disease

(30 min)

Dr. Anna Mathew

Proteinuria as a Surrogate Outcome (30 min)

Dr. Lonnie Pyne

Room: Manitoba

Young Investigator Forum Programming

Room: World Trade Centre Conference AB 6th Floor

11:30 – 12:30 Lunch

Room: Saskatchewan/Manitoba

12:30 – 13:30 Vancouver 2010 Lecture

Equity as a Driver of Innovation: Women in Hypertension Science, Studies and Guidelines (30 min)

Dr. Doreen Rabi

The Need for Explaining ‘Sex’ to Clinical Practitioners (30 min)

Dr. Colleen Norris

Room: British Columbia/Alberta/Yukon

Young Investigator Forum Programming

Room: World Trade Centre Conference AB 6th Floor

13:30 – 13:45 Networking & Health Break in Foyer
13:45 – 14:45 The Canadian Dyslipidemia Guidelines Update (30 min)

Dr. Glen Pearson

Does Bedtime Dosing of Antihypertensives Improve Mortality or Morbidity? (30 min)

Dr. Scott Garrison

Room: British Columbia/Alberta/Yukon

Resistant Hypertension (30 min)

Dr. Karen Tran

Hypertensive Emergency vs Urgency: When to send your Patient to ER (30 min)

Dr. Ann Bugeja

Room: Turner Valley

Young Investigator Forum Programming

Room: World Trade Centre Conference AB 6th Floor

14:45 Congress Ends